RecruitingPhase 4NCT06723145
Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Sponsor
Kyoto University
Enrollment
1,200 participants
Start Date
Jan 20, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate the impact of perioperative aspirin continuation on clinical outcomes in patients with a history of coronary stent implantation who are scheduled for abdominal surgery.
Eligibility
Min Age: 20 Years
Inclusion Criteria2
- Patients with a history of coronary stenting and scheduled for abdominal surgery
- Patients on a single antiplatelet agent
Exclusion Criteria7
- Patients on dual antiplatelet therapy (DAPT)
- Patients on anticoagulation therapy
- Patients with a history of stent thrombosis
- Patients with CHADS2 score >= 5
- Patients at extremely high risk of bleeding and unable to continue preoperative aspirin
- Patients incapable of consent, including those under 20 years of age
- Other patients for whom either discontinuation or continuation of antiplatelet agents is deemed inappropriate by the attending physician
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAspirin
perioperative aspirin continuation
DRUGAspirin interruption
Aspirin interruption 5-7 days before surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06723145
Related Trials
A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease
NCT075249981 location
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
NCT069623061 location
Paired Comparison of SVV and PVI Accuracy
NCT072608901 location
Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery
NCT060926711 location
Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications
NCT072872801 location